Flo Health, the leading women’s health app globally, has received over $200 million (£155.7m) in funding from General Atlantic. This investment has pushed the company’s value above $1 billion, making it the first digital women’s health app to achieve unicorn status. Flo Health is dedicated to supporting women through every stage of their health journey, from menstruation to pregnancy and menopause.
With a team of more than 120 doctors and health experts, Flo offers comprehensive cycle and ovulation tracking, allowing users to monitor over 70 symptoms and access various features to manage their health effectively. Additionally, Flo provides personalized health insights, expert tips, daily visual content, and access to a private digital community focused on health and wellness.
The partnership with General Atlantic will help Flo Health expand into new user segments, enhance their tech-driven health insights, and pursue strategic growth opportunities. Co-founder and CEO, Dimitry Gurski, expressed excitement about reaching unicorn status and the impact on the femtech industry.
Furthermore, Flo is committed to providing free access to Flo Premium in 66 countries, benefiting millions of women globally. The investment will support Flo’s mission of normalizing conversations about women’s health and raising awareness on a global scale.
By increasing R&D headcount and leveraging General Atlantic’s expertise, Flo aims to continue its growth trajectory and innovate in the women’s health and wellness ecosystem. Jessie Cai from General Atlantic expressed confidence in Flo’s vision and potential to lead the women’s health category.
As technology continues to play a crucial role in women’s health, Flo Health’s funding milestone marks a significant moment in empowering women to take control of their health decisions and access vital health data.
